Arkolith/Insider Trading/ADMP/Form 4

Versi Jannine

DirectorAdamis Pharmaceuticals Corp (ADMP) · full profile →Form 4 · filed May 30, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2023Grant(A)177K——177K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 25, 2023Grant(A)2K——2K
May 25, 2023Grant(A)5K——5K
May 25, 2023Grant(A)5K——5K
May 25, 2023Grant(A)5K——5K
May 25, 2023Grant(A)5K——5K
May 25, 2023Grant(A)5K——5K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001839882-23-013974) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML